Fatal fulminant hepatitis associated with bromfenac use

Annals of Pharmacotherapy

Volumn 33, Issue 9, 1999, Pages 945-947

  Rabkin, John M ^a   Smith, Megan J ^b   Orloff, Susan L ^b   Corless, Christopher L ^b   Stenzel, Peter ^b   Olyaei, Ali J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

Bromfenac; Hepatic failure

Indexed keywords

BROMFENAC; DEXFENFLURAMINE; FENFLURAMINE; MIBEFRADIL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; TOXIC HEPATITIS;

EID: 0032863690     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18364     Document Type: Article

References (9)

1. Fry SW, Seeff LB. Hepatotoxicity of analgesics and anti-inflammatory agents. Gastroenterol Clin North Am 1995;24:875-905.
2. Prescott LF. Liver damage with non-narcotic analgesics. Med Toxicol 1986;1(suppl 1):44-56.
3. Garcia Rodriguez LA, Perez Gutthann S, Walker AM, Lueck L. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ 1992; 305:865-8.
4. Boelsterli UA, Zimmerman HJ, Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal anti-inflammatory drugs: molecular mechanisms and pathology. Crit Rev Toxicol 1995;25:207-35.
5. Package insert. Duract (bromfenac). Philadelphia, PA: Wyeth-Ayerst, 1997.
6. Ishak KG, Zimmerman HJ. Morphologic spectrum of drug-induced hepatic disease. Gastroenterol Clin North Am 1995;24:759-86.
7. Zimmerman HJ. Hepatotoxicity. Disease-a-month 1993;39:675-769.
8. Lee RG. Chronic hepatitis. In: Bone RC, Greenberger NJ, Khohler PO, Levin S, Lipschitz DA, eds. Diagnostic liver pathology. St. Louis, MO: Mosby-Year Book Inc., 1994:57-80.
9. The Pink Sheet. Bethesda, MD: Food and Drug Administration, June 29, 1998:13-4.